HIGHLIGHTS
- who: January and collaborators from the Development, South University of the Witwatersrand, South have published the research work: Orphan drugs clinical uncertainty and prices: Addressing allocative and technical inef ciencies in orphan drug reimbursement, in the Journal: (JOURNAL)
- what: To conclude, the authors propose solutions to help address these potential risks. The authors compare costs in the year 2021 (the most recent year for which data are available) with the year 2013 (the earliest year for which such granular data are available; data were not inflation-adjusted) to have a long enough time span to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.